Key result
Multifetal gestation linked to ~174% higher risk of PPCM vs. singleton pregnancy.
Why the study?
The adjusted magnitude of multifetal gestation as an independent risk factor for peripartum cardiomyopathy remains uncertain.
Multifetal gestation is an independent risk factor for peripartum cardiomyopathy, driven by increased hemodynamic load and anti-angiogenic signaling, warranting intensified clinical surveillance.
Warrants closer peripartum cardiomyopathy surveillance in multifetal gestations; confirms independent risk factor status in meta-analyses.
Background. Peripartum cardiomyopathy is an idiopathic left ventricular systolic heart-failure syndrome presenting in late pregnancy or up to five months postpartum, with global incidence ranging from 1 per 1000–4000 births in North America and Europe to 1 per 100–300 in parts of sub-Saharan Africa. Multifetal gestation is a recurring risk factor, though its adjusted magnitude is uncertain. Aim. To synthesise contemporary evidence on whether multifetal gestation constitutes an independent, mechanistically grounded PPCM risk factor. Methods. A structured narrative review (January 2000–March 2026) of PubMed/MEDLINE, Scopus, and Web of Science records, supplemented by reference-list and guideline cross-referencing, including peer-reviewed primary studies, systematic or narrative reviews, and meta-analyses on PPCM epidemiology, hemodynamics, molecular biology, therapy, and prognosis in multifetal versus singleton gestations. Results. A 2024 Finnish record-linkage study identified twin pregnancy as conferring an adjusted odds ratio of 2.74 (95% CI 1.37–5.49, p = 0.005) for peripartum heart failure, comparable to pre-eclampsia (aOR 2.43) (Puhakka et al., 2024). Twin gestation imposes 20% greater cardiac output, 15% greater stroke volume, and 13.5% greater left ventricular mass than singleton pregnancy, with progressive third-trimester loss of long-axis systolic efficiency (Kametas, 2003). A 2025 systematic review confirmed multifetal gestation as a recurrent risk factor across diverse cohorts (Dewi et al., 2025), corroborated by a 2022 global meta-analysis of over 7,000 cases from 41 studies (Hoevelmann et al., 2022). Conclusions. Multifetal gestation is an independent PPCM risk factor of comparable magnitude to pre-eclampsia, mediated by hemodynamic loading and amplified anti-angiogenic signalling on a genetic substrate (Davis et al., 2020). Incorporation of pregnancy plurality into stratified PPCM risk models is justified by this synthesis (Jackson et al., 2023).
No takes yet. Share an insight, caveat, or question.
Ptach et al. (2026) conducted a review in Peripartum Cardiomyopathy. Multifetal gestation vs. Singleton gestation was evaluated on Incidence of peripartum heart failure (aOR 2.74, 95% CI 1.37-5.49, p=0.005). Multifetal gestation acts as an independent risk factor for peripartum cardiomyopathy, conferring an adjusted odds ratio of 2.74 compared to singleton pregnancies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: